FDA Cuts Red Tape for Cancer Gene Tests, Patients Rejoice
Published Date: 11/25/2025
Proposed Rule
Summary
The FDA wants to change the rules for certain cancer-related genetic test systems, making them easier to get approved by moving them from a strict Class III to a more flexible Class II category. This affects companies making these tests and could speed up how quickly patients get access to important cancer treatments. Comments on this change are open until January 26, 2026, so now’s the time to speak up!
Analyzed Economic Effects
4 provisions identified: 3 benefits, 1 costs, 0 mixed.
Class III → Class II: 510(k) Instead of PMA
The FDA proposes to reclassify certain nucleic acid-based oncology test systems (product codes OWD, PJG, PQP, and SFL) from Class III (PMA) to Class II (special controls). If finalized, manufacturers would no longer need a Premarket Approval (PMA) but must submit a premarket notification (510(k)) before marketing these devices.
Faster Patient Access to Cancer Tests
FDA says reclassifying these oncology nucleic acid-based test systems to Class II and using the 510(k) pathway may result in shorter premarket review timelines and enable more manufacturers to develop these tests, which could provide more timely access to tests that guide cancer treatment decisions.
Use of Predetermined Change Control Plans
Manufacturers may use FDA-authorized predetermined change control plans (PCCPs) to implement future modifications described in an approved PCCP without submitting a new 510(k) or PMA supplement for each change, under section 515C of the FD&C Act (FDORA, enacted December 29, 2022).
Prescription IVD Labeling Requirement
If reclassified to Class II, these devices will be identified as prescription in vitro diagnostics (IVDs) and will be subject to prescription labeling requirements for IVD products (see 21 CFR 809.10(a)(4) and (b)(5)(ii)).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2025-20949, Modification of Class E Airspace; Driggs/Reed Memorial Airport, Driggs, ID
The FAA wants to change the airspace rules around Driggs/Reed Memorial Airport in Idaho to make flying safer and easier for pilots using instruments. This update mainly affects pilots and air traffic controllers and won’t cost anyone extra. If you have thoughts, you’ve got until January 9, 2026, to speak up!
Next: 2025-21087, Enhanced Transparency and Public Accountability of the Supervisory Stress Test Models and Scenarios; Modifications to the Capital Planning and Stress Capital Buffer Requirement Rule, Enhanced Prudential Standards Rule, and Regulation LL; Extension of Comment Period
The Federal Reserve is making its bank stress tests clearer and easier to understand for everyone. Banks will see some changes in how these tests work starting in 2026, helping keep our money safe. You’ve got until February 21, 2026, to share your thoughts on these updates!